Altered expression of the DISC1 gene in peripheral blood of patients with schizophrenia

BMC Med Genet. 2020 Oct 2;21(1):194. doi: 10.1186/s12881-020-01132-9.

Abstract

Background: Schizophrenia is a severe, heritable, and refractory psychiatric disorder. Several studies have shown that the disrupted in schizophrenia 1 (DISC1) gene is closely associated with schizophrenia by its role in neuronal morphology, synaptic function, brain development, and dopamine homeostasis etc. This study intended to investigate the expression levels of DISC1 gene in schizophrenia patients compared with healthy controls, and the expression variation of DISC1 gene before and after antipsychotic treatment in schizophrenia patients.

Methods: In this study, we compared DISC1 expression levels in blood of 48 healthy controls, and 32 schizophrenia patients before and after 12 weeks of antipsychotic treatment using real-time quantitative PCR (RT-qPCR) analysis.

Results: The expression levels of DISC1 gene in peripheral blood mononuclear cells of schizophrenia patients before antipsychotic treatment were higher than those in healthy controls (P < 0.01); whereas after antipsychotic treatment, the expression levels of DISC1 gene in peripheral blood mononuclear cells of schizophrenia patients still remained increased (P < 0.01).

Conclusions: Our study provided further support for the involvement of DISC1 in the development of schizophrenia.

Keywords: Antipsychotics; DISC1; Schizophrenia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Female
  • Gene Expression*
  • Humans
  • Leukocytes, Mononuclear / drug effects*
  • Leukocytes, Mononuclear / metabolism
  • Male
  • Middle Aged
  • Nerve Tissue Proteins / blood
  • Nerve Tissue Proteins / genetics*
  • Schizophrenia / blood
  • Schizophrenia / drug therapy
  • Schizophrenia / genetics*
  • Young Adult

Substances

  • Antipsychotic Agents
  • DISC1 protein, human
  • Nerve Tissue Proteins